Optimised plasma sample preparation and LC-MS analysis to support large-scale proteomic analysis of clinical trial specimens: Application to the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) trial.

Proteomics Clin Appl · 2023 · PMC10909541 · PMID 36891577

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Minor increases in the major HDL lipoproteins Apo‐AI and Apo‐AII were observed after 6‐weeks of fenofibrate, although this trend did not reach statistical significance in this small cohort.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.